Cited by 53Pancreatic and Hepatic Oncology ResearchBRCA gene mutations in cancerGenetic factors in colorectal cancer

Familial pancreatic adenocarcinoma

Open access
Petersen, Gloria M.·2015·Hematology/Oncology Clinics of North America

Abstract

Familial pancreatic cancer (FPC) kindreds have at least 2 first-degree relatives with pancreatic ductal adenocarcinoma. Studies of FPC have focused on the discovery of genetic cause and on the management of those at genetically high risk. Research reveals that a half dozen known hereditary syndromes or genes are associated with increased risk of developing pancreatic cancer, the most prominent of which are BRCA2 and CDKN2A. Genetic risk assessment and testing is already available. Owing to limited experience worldwide, guidance is often based on expert opinion, although all agree that research is needed to improve the shaping of options.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.hoc.2015.04.007

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High-risk groups for pancreatic ductal adenocarcinoma include people with inherited predisposition, people with pancreatic cystic lesions, and people older than 50 years with newly diagnosed type 2 diabetes.

    “Here, we review groups at high risk for pancreatic ductal adenocarcinoma, including individuals with inherited predisposition and patients with pancreatic cystic lesions.”

    From Early detection of pancreatic cancer (2020) · cites this paper as [17]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Petersen, G. M.
Affiliations
Mayo Clinic (US)
Corresponding author
Petersen, Gloria M.
Venue
Hematology/Oncology Clinics of North America
Publisher
Elsevier BV
Published
2015-08
Volume
29
Issue
4
Pages
641-653
ISSN
0889-8588 (ISSN-L)
OpenAlex
W2111337996
Cited by
53
References
57
Citations by year
2026: 2 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 8 · 2020: 9 · 2019: 6 · 2018: 5 · 2017: 7 · 2016: 3 · 2015: 1
FWCI
0.57
Type
journal article
Language
en
Open access
Locations
  • Hematology/Oncology Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (P50CA102701, R01CA097075)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords
familial pancreatic cancer, pancreatic ductal adenocarcinoma, hereditary cancer, BRCA2, CDKN2A, genetic risk prediction, genetic testing, high-risk individuals, cancer prevention
MeSH terms
Adenocarcinoma, Carcinoma, Genetic Testing, Humans, Pancreatic Neoplasms, Risk Factors, Germ-Line Mutation, Genetic Predisposition to Disease, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review